VET
Vermilion Energy Inc.
Oil & Gas Exploration & Production
Market Cap$1.71B
5Y Perf.+150.0%
Build Your Comparison
Side-by-side financial analysisVET
CVE
JPM
Try popular comparisons:
Stock Comparison
VET vs CVE vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
CVE
Cenovus Energy Inc.
Oil & Gas Integrated
Market Cap$53.24B
5Y Perf.+505.4%
JPM
JPMorgan Chase & Co.
Banks - Diversified
Market Cap$896.00B
5Y Perf.+241.0%
VET vs CVE vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot |  VET |  CVE |  JPM |
|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Banks - Diversified |
| Market Cap | $1.71B | $53.24B | $896.00B |
| Revenue (TTM) | $1.81B | $49.40B | $280.33B |
| Net Income (TTM) | $-814M | $4.64B | $57.05B |
| Gross Margin | 35.9% | 19.6% | 60.0% |
| Operating Margin | 20.2% | 14.0% | 25.9% |
| Forward P/E | 11.2x | 6.2x | 14.4x |
| Total Debt | $1.30B | $17.00B | $942.38B |
| Cash & Equiv. | $19M | $2.74B | $343.34B |
VET vs CVE vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
VET
CVE
JPM
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Vermilion Energy In… (VET) | 100 | 250.0 | +150.0% |
| Cenovus Energy Inc. (CVE) | 100 | 605.4 | +505.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VET vs CVE vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CVE leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. JPMorgan Chase & Co. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇CVE emerged as the overall leader. Track its performance:
VET
Vermilion Energy Inc.
The Income Pick
VET is the clearest fit if your priority is dividends.
- 4.1% yield, 3-year raise streak, vs JPM's 1.9%
Best for: dividends
CVE
Cenovus Energy Inc.
The Income Pick
CVE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.08, yield 2.0%
- Rev growth -14.0%, EPS growth 28.7%, 3Y rev CAGR -11.6%
- Lower volatility, beta 0.08, Low D/E 53.8%, current ratio 1.57x
Best for: income & stability and growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs CVE's 109.7%
- 3.3% NII/revenue growth vs VET's -15.0%
- 20.4% margin vs VET's -44.9%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth |  JPM | 3.3% NII/revenue growth vs VET's -15.0% |
| Value |  CVE | Lower P/E (6.2x vs 14.4x) |
| Quality / Margins | JPM | 20.4% margin vs VET's -44.9% |
| Stability / Safety | CVE | Beta 0.08 vs JPM's 0.94, lower leverage |
| Dividends |  VET | 4.1% yield, 3-year raise streak, vs JPM's 1.9% |
| Momentum (1Y) | CVE | +100.1% vs JPM's +21.8% |
| Efficiency (ROA) | CVE | 7.8% ROA vs VET's -13.8%, ROIC 7.9% vs 3.5% |
VET vs CVE vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2020
FY 2025
VET vs CVE vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLVETLAGGINGJPM
JPMJPMorgan Chase & Co.
1leads
CVECenovus Energy Inc.
1leads
VETVermilion Energy Inc.
1leads
6 Total Categories
CATEGORYLEADERvs CVEvs JPMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
JPM4/6
Valuation MetricsMultiples, price ratios, and targets
VET5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CVE5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 154.6x VET's $1.8B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to VET's -44.9%. On growth, CVE holds the edge at -12.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | VETVermilion Energy … | CVECenovus Energy In… | JPMJPMorgan Chase & … |
|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $49.4B | $280.3B |
| EBITDAEarnings before interest/tax | $1.2B | $12.4B | $81.4B |
| Net IncomeAfter-tax profit | -$814M | $4.6B | $57.0B |
| Free Cash FlowCash after capex | $301M | $4.4B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +35.9% | +19.6% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +14.0% | +25.9% |
| Net MarginNet income ÷ Revenue | -44.9% | +9.4% | +20.4% |
| FCF MarginFCF ÷ Revenue | +16.6% | +8.8% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.4% | -12.8% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -10.9% | +78.7% | +16.0% |
JPM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
VET leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 13% valuation discount to CVE's 18.4x P/E. On an enterprise value basis, VET's 3.9x EV/EBITDA is more attractive than JPM's 18.4x.
| Metric | VETVermilion Energy … | CVECenovus Energy In… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Market CapShares × price | $1.7B | $53.2B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $63.4B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | -3.68x | 18.38x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.20x | 6.18x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 3.92x | 9.04x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 1.50x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.08x | 2.28x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 7.32x | 21.86x | 8.88x |
VET leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
CVE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-34 for VET. CVE carries lower financial leverage with a 0.54x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CVE scores 6/9 vs VET's 3/9, reflecting solid financial health.
| Metric | VETVermilion Energy … | CVECenovus Energy In… | JPMJPMorgan Chase & … |
|---|---|---|---|
| ROE (TTM)Return on equity | -33.7% | +15.2% | +15.9% |
| ROA (TTM)Return on assets | -13.8% | +7.8% | +1.3% |
| ROICReturn on invested capital | +3.5% | +7.9% | +4.5% |
| ROCEReturn on capital employed | +3.3% | +8.2% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.59x | 0.54x | 2.60x |
| Net DebtTotal debt minus cash | $1.3B | $14.3B | $599.0B |
| Cash & Equiv.Liquid assets | $19M | $2.7B | $343.3B |
| Total DebtShort + long-term debt | $1.3B | $17.0B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 11.80x | 0.74x |
CVE leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — CVE and JPM each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVE five years ago would be worth $30,275 today (with dividends reinvested), compared to $14,136 for VET. Over the past 12 months, CVE leads with a +100.1% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs VET's 1.3% — a key indicator of consistent wealth creation.
| Metric | VETVermilion Energy … | CVECenovus Energy In… | JPMJPMorgan Chase & … |
|---|---|---|---|
| YTD ReturnYear-to-date | +31.7% | +62.1% | -0.5% |
| 1-Year ReturnPast 12 months | +45.6% | +100.1% | +21.8% |
| 3-Year ReturnCumulative with dividends | +4.0% | +79.1% | +138.2% |
| 5-Year ReturnCumulative with dividends | +41.4% | +202.8% | +118.2% |
| 10-Year ReturnCumulative with dividends | -39.7% | +109.7% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +1.3% | +21.4% | +33.6% |
Evenly matched — CVE and JPM each lead in 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — VET and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
VET is the less volatile stock with a -0.18 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs VET's 75.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | VETVermilion Energy … | CVECenovus Energy In… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.18x | 0.08x | 0.94x |
| 52-Week HighHighest price in past year | $14.82 | $32.07 | $337.25 |
| 52-Week LowLowest price in past year | $7.00 | $13.47 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +88.2% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 48.8 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 7.9M | 7.0M |
Evenly matched — VET and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — VET and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VET as "Hold", CVE as "Hold", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -3.7% for VET (target: $11). For income investors, VET offers the higher dividend yield at 4.10% vs JPM's 1.86%.
| Metric | VETVermilion Energy … | CVECenovus Energy In… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $10.74 | $29.00 | $339.75 |
| # AnalystsCovering analysts | 10 | 27 | 61 |
| Dividend YieldAnnual dividend ÷ price | +4.1% | +2.0% | +1.9% |
| Dividend StreakConsecutive years of raises | 3 | 5 | 15 |
| Dividend / ShareAnnual DPS | $0.64 | $0.78 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +3.4% | +3.9% |
Evenly matched — VET and JPM each lead in 1 of 2 comparable metrics.
Key Takeaway
JPM leads in 1 of 6 categories (Income & Cash Flow). VET leads in 1 (Valuation Metrics). 3 tied.
Best OverallVermilion Energy Inc. (VET)Leads 1 of 6 categories
Loading custom metrics...
VET vs CVE vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VET or CVE or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -15. 0% for Vermilion Energy Inc. (VET). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VET or CVE or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Cenovus Energy Inc. at 18. 4x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 6. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — VET or CVE or JPM?
Over the past 5 years, Cenovus Energy Inc.
(CVE) delivered a total return of +202. 8%, compared to +41. 4% for Vermilion Energy Inc. (VET). Over 10 years, the gap is even starker: JPM returned +465. 8% versus VET's -39. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VET or CVE or JPM?
By beta (market sensitivity over 5 years), Vermilion Energy Inc.
(VET) is the lower-risk stock at -0. 18β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -617% more volatile than VET relative to the S&P 500. On balance sheet safety, Cenovus Energy Inc. (CVE) carries a lower debt/equity ratio of 54% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — VET or CVE or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -15. 0% for Vermilion Energy Inc. (VET). On earnings-per-share growth, the picture is similar: Cenovus Energy Inc. grew EPS 28. 7% year-over-year, compared to -1313. 3% for Vermilion Energy Inc.. Over a 3-year CAGR, CVE leads at -11. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VET or CVE or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -37. 0% for Vermilion Energy Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 8. 8% for CVE. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VET or CVE or JPM more undervalued right now?
On forward earnings alone, Cenovus Energy Inc.
(CVE) trades at 6. 2x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 8. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — VET or CVE or JPM?
All stocks in this comparison pay dividends.
Vermilion Energy Inc. (VET) offers the highest yield at 4. 1%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is VET or CVE or JPM better for a retirement portfolio?
For long-horizon retirement investors, Vermilion Energy Inc.
(VET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 18), 4. 1% yield). Both have compounded well over 10 years (VET: -39. 7%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VET and CVE and JPM?
These companies operate in different sectors (VET (Energy) and CVE (Energy) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VET is a small-cap income-oriented stock; CVE is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.